| The weekly deal flow update Curated by Zoic Capital. [subscribe] |
| The deals that we thought were notable this week: Healionics: is addressing the critical need for improved means of vascular access for hemodialysis in patients with kidney failure. Innovative Solutions from Engineered Biomaterials. Healionics’ Adrienne Oda in Forbes magazine’s “30 Under 30“ – Forbes Tissue Analytics: digitization of wound size measurement. Wound-tracking startup Tissue Analytics raises $5M Series A.- Technical.ly A San Francisco firm led the round. The health IT company is looking to hire at its Inner Harbor tech office. Bell Biosystems: Magnetic beads / nanoparticles that allow for tracking of stem cells in vivo to determine effectiveness and location during therapy. Bell Biosystems, Inc. Announces Pre-Clinical Results of Major in Vivo Safety Study Milestone. –markets.businessinsider.com POWTI Innovations (Point of Wounding Trauma Indicator): On-body trauma event detection device, communicates with first responders. Video POWTI Innovations: For those who risk their lives everyday. The world’s first automated standalone traumatic injury detection device worn on body. When traumatic event occurs, the location is transmitted VIA Cellular GSM and satellite. Location data is received by emergency rescue personnel enabling rapid response of emergency responders. Adhesys Medical: surgical adhesive that has faster bonding and greater strength than current ones, looking at topical / wound healing applications. Grünenthal Group receives CE-Certification for innovative surgical sealant. Aachen, Germany (ots) – Grünenthal announced today that Adhesys Medical GmbH, a wholly-owned subsidiary of the Grünenthal Group, has received CE-Certification for MAR-CUTIS.- presseportal.de Flow Neuroscience, a Stockholm, Sweden-based medtech company, secured a $1.1m seed round of funding. FINSMES. Backers included Khosla Ventures, SOSV and a Swedish angel investor. Led by CEO and clinical psychologist Daniel Månsson, Flow Neuroscience is developing a new treatment for depression combining brain stimulation with behavioral therapy. The funding will enable Flow to complete the regulatory process, get its first product approved in the EU, and grow its team. Multiple Myeloma Pharmaceutical, the FDA clears test for assessing patients treated with Multiple Myeloma Drug. –360Dx Sebia and Janssen Biotech collaborated on the development of the test, which is for assessing patients treated with Darzalex.Millipede, a heart valve repair device receives 90m startup investment from Boston Scientific. – Xconomy Boston Scientific is infusing medical device company Millipede with $90 million, an equity investment that comes with the option to acquire the startup. Tyto Care, an Israeli telemedicine company, is developing devices making it possible to carry out common tests in family medicine at the patient’s home without visiting a doctor, has raised $25 million in a financing round intended to reach $28-31 million, according to an announcement by Teuza – A Fairchild Technology Venture Ltd. which will own 3% of Tyto after the round. – Globes English Articles from the week that left a lot of good questions for the Zoic team. The first is a list of 12 books compiled to reshape our perceptions of the world. The second is a study illustrating the historical significance of today’s asset markets where investors can view US equity prices since 1871, Dutch bond yields since 1517, the oil price since 1861, risk premia since 1900 and German dividend yields since 1869 among many other charts. The third is related to inverse design principles to create highly efficient broadband metadevices. |
 Curated by the team at Zoic Capital. |
Innovative Solutions with Engineered Biomaterials
Recommended For You
Neuralink and the Long Path to Approval
Neuralink and the Long Path to Approval
zoicaccountSeptember 11, 2021
As 2021 begins, we reflect on scientific advancements in 2020 spurred by the COVID-19 crisis
As 2021 begins, we reflect on scientific advancements in 2020 spurred by the COVID-19 crisis
zoicaccountJanuary 31, 2021
COVID-19, Alzheimer’s, and Cancer Testing
COVID-19, Alzheimer’s, and Cancer Testing
zoicaccountDecember 7, 2020